|
Volumn 101, Issue 2, 2009, Pages 225-226
|
Thrombotic microangiopathies as a prime example for translational medicine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AUTOANTIBODY;
RITUXIMAB;
VON WILLEBRAND FACTOR CLEAVING PROTEINASE;
EDITORIAL;
HEMOLYTIC UREMIC SYNDROME;
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS;
MENTAL CONCENTRATION;
PATHOGENESIS;
PRIORITY JOURNAL;
PROGNOSIS;
RETINA MACULA AGE RELATED DEGENERATION;
THROMBOSIS;
THROMBOTIC THROMBOCYTOPENIC PURPURA;
ANIMAL;
BLOOD;
BLOOD CLOTTING;
GENETIC PREDISPOSITION;
HUMAN;
MEDICAL RESEARCH;
MICROCIRCULATION;
PATHOLOGY;
PATHOPHYSIOLOGY;
RISK FACTOR;
ANIMALS;
AUTOANTIBODIES;
BIOMEDICAL RESEARCH;
BLOOD COAGULATION;
GENETIC PREDISPOSITION TO DISEASE;
HEMOLYTIC-UREMIC SYNDROME;
HUMANS;
MICROCIRCULATION;
PURPURA, THROMBOTIC THROMBOCYTOPENIC;
RISK FACTORS;
|
EID: 62449095157
PISSN: 03406245
EISSN: None
Source Type: Journal
DOI: 10.1160/TH08-12-0819 Document Type: Editorial |
Times cited : (3)
|
References (7)
|